Immunohistochemical detection of p16INK4a in dysplastic lesions of the oral cavity

Modern Pathology

Volumn 19, Issue 10, 2006, Pages 1310-1316

  Bradley, Kyle T ^a   Budnick, Steven D ^a   Logani, Sanjay ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Biomarker; Oral dysplasia; p16INK4a immunohistochemistry

Indexed keywords

BIOLOGICAL MARKER; EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY; PROTEIN P16; PROTEIN P16INK4A;

ARTICLE; CANCER GRADING; CLINICAL PRACTICE; DISEASE SEVERITY; EPITHELIUM DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MOUTH CAVITY; MOUTH MUCOSA; ORAL BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; CHEMISTRY; DOWN REGULATION; MOUTH TUMOR; NEOPLASM; PATHOLOGY; PRECANCER; RETROSPECTIVE STUDY;

CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASMS, GLANDULAR AND EPITHELIAL; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES;

EID: 33748860116     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800649     Document Type: Article

References (45)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-2492.
3. Barnes L. Diseases of the larynx, hypopharynx and esophagus. In: Barnes L (ed). Surgical Pathology of the Head and Neck, 2nd edn. Marcel Dekker Inc.: New York, 2001, pp 127-237.
4. Kramer IR, Lucas RB, Pindborg JJ, et al. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978;46:518-539.
5. Brothwell DJ, Lewis DW, Bradley G, et al. Observer agreement in the grading of oral epithelial dysplasia. Commun Dent Oral Epidemiol 2003;31:300-305.
6. Sudbø J, Bryne M, Johannessen AC, et al. Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia. J Pathol 2001;194:303-310.
7. Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80:188-191.
8. Karabulut A, Reibel J, Therkildsen MH, et al. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 1995;24: 198-200.
9. Pindborg JJ, Reibel J, Holmstrup P. Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol 1985;14: 698-708.
10. Nagpal JK, Das BR. Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncol 2003;39:213-221.
11. El-Naggar AK, Hurr K, Batsakis JG, et al. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res 1995;55:2656-2659.
12. Williams HK. Molecular pathogenesis of oral squamous carcinoma. Mol Pathol 2000;53:165-172.
13. Sartor M, Steingrimsdottir H, Elamin F, et al. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. Br J Cancer 1999;80:79-86.
14. van der Riet P, Nawroz H, Hruban RH, et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 1994;54:1156-1158.
15. Nawroz H, van der Riet P, Hruban RH, et al. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994;54:1152-1155.
16. Prime SS, Eveson JW, Guest PG, et al. Early genetic and functional events in the pathogenesis of oral cancer. Radiat Oncol Investig 1997;5:93-96.
17. Patel V, Leethanakul C, Gutkind JS. New approaches to the understanding of the molecular basis of oral cancer. Crit Rev Oral Biol Med 2001;12:55-63.
18. Partridge M, Emilion G, Peteromichelakis S, et al. Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. Int J Cancer 1999;83:318-325.
19. Field JK. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol 1992;28B:67-76.
20. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996;56: 3630-3633.
21. Papadimitrakopoulou V, Izzo J, Lippman SM. Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene 1997;14:1799-1803.
22. Mao L, Lee JS, Fan YH, et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996;2:682-685.
23. Zhang L, Rosin MP. Loss of heterozygosity: a potential tool in management of oral premalignant lesions? J Oral Pathol Med 2001;30:513-520.
24. Lee NK, Ye Y, Chen J, et al. p53, retinoblastoma, and human papillomavirus in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg 1993;119:1125-1131.
25. Olshan AF, Weissler MC, Pei H, et al. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene 1997;14:811-818.
26. Saito T, Nakajima T, Mogi K. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. J Oral Pathol Med 1999;28:226-232.
27. Pande P, Mathur M, Shukla NK, et al. pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncol 1998;34:396-403.
28. Klaes R, Friedrich T, Spitovsky D, et al. Overexpression of p16INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-284.
29. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-1399.
30. Sano T, Masuda N, Oyama T, et al. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int 2002;52:375-383.
31. Dray M, Russell P, Dalrymple C, et al. p16INK4a as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. Pathology 2005;37:112-124.
32. Murphy N, Ring M, Heffron CC, et al. p16INK4a, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 2005;58:525-534.
33. Gologan O, Barnes EL, Hunt JL. Potential diagnostic use of p16INK4a, a new marker that correlates with dysplasia in oral squamoproliferative lesions. Am J Surg Pathol 2005;29:792-796.
34. Ai L, Stephenson KK, Ling W, et al. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Mod Pathol 2003;16:944-950.
35. Waber P, Dlugosz S, Cheng Q, et al. Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a. Oncogene 1997;15: 1699-1704.
36. Cairns P, Polascik TJ, Eby Y, et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 1995;11:210-212 [letter].
37. Pavelic ZP, Lasmar M, Pavelic L, et al. Absence of retinoblastoma gene product in human primary oral cavity carcinomas. Eur J Cancer B Oral Oncol 1996; 32B:347-351.
38. Yoo GH, Xu HJ, Brennan JA, et al. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 1994;54:4603-4606.
39. Paradiso A, Ranieri G, Stea B, et al. Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer. Int J Oncol 2004;24: 249-255.
40. Vinokurova S, Wentzensen N, von Knebel Doeberitz M. Analysis of p16INK4a and integrated HPV genomes as progression markers. In: Davy C, Doorbar J (eds). Methods in Molecular Medicine, Vol 119. Human Papillomaviruses: Methods and Protocols. Humana Press Inc.: Totowa, NJ, 2005, pp 73-83.
41. Fregonesi PA, Teresa DB, Duarte RA, et al. p16INK4a immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem 2003;51: 1291-1297.
42. González-Moles MA, Ruiz-Avila I, González-Moles S, et al. Detection of HPV DNA by in situ hybridization in benign, premalignant and malignant lesions of the oral mucosa. Bull Group Int Rech Sci Stomatol Odontol 1994;37:79-85.
43. Bouda M, Gorgoulis VG, Kastrinakis NG, et al. 'High risk' HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 2000;13:644-653.
44. Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2004;32(Suppl 1):S59-S66.
45. Sugiyama M, Bhawal UK, Dohmen T, et al. Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:594-600.